Literature DB >> 414288

Hypnoticlike effects of cannabidiol in the rat.

J M Monti.   

Abstract

The actions of cannabidiol (CBD), one of the cannabis constituents, were assessed on the sleep-wakefulness cycle of male Wistar rats. During acute experiments, single doses of 20 mg/kg CBD decreased slow-wave sleep (SWS) latency. After 40 mg/kg SWS time was significantly increased while wakefulness was decreased. REM sleep was not significantly modified. Following the once-daily injections of 40 mg/kg CBD for a period of 15 days, tolerance developed to all the above-mentioned effects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 414288     DOI: 10.1007/bf00497858

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  6 in total

1.  Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.

Authors:  R N Takahashi; I G Karniol
Journal:  Psychopharmacologia       Date:  1975

2.  Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol.

Authors:  I G Karniol; E A Carlini
Journal:  Psychopharmacologia       Date:  1973-10-23

3.  Electroencephalographic study of the effects of tetrahydrocannabinols on sleep in the rat.

Authors:  J E Moreton; W M Davis
Journal:  Neuropharmacology       Date:  1973-09       Impact factor: 5.250

Review 4.  The pharmacology of rapid eye movement sleep.

Authors:  C D King
Journal:  Adv Pharmacol Chemother       Date:  1971

5.  The effect of lesions of ascending noradrenaline pathways on sleep and waking in the rat.

Authors:  P Lidbrink
Journal:  Brain Res       Date:  1974-07-05       Impact factor: 3.252

6.  Spontaneous behavior and sleep-wakefulness cycle in isolated and paired REM sleep deprived-marihuana treated rats.

Authors:  J M Monti; E A Carlini
Journal:  Pharmacol Biochem Behav       Date:  1975 Nov-Dec       Impact factor: 3.533

  6 in total
  12 in total

1.  Effects of cannabidiol in animal models predictive of antipsychotic activity.

Authors:  A W Zuardi; J A Rodrigues; J M Cunha
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Interaction of cannabidiol and alcohol in humans.

Authors:  P Consroe; E A Carlini; A P Zwicker; L A Lacerda
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

Review 4.  The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products.

Authors:  Jinpeng Li; Ricardo Carvajal; Leon Bruner; Norbert E Kaminski
Journal:  Food Chem Toxicol       Date:  2021-10-06       Impact factor: 5.572

5.  Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.

Authors:  A W Zuardi; I Shirakawa; E Finkelfarb; I G Karniol
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep quality in emerging adults: a pilot study.

Authors:  Kristin E Maple; Kymberly A McDaniel; Skyler G Shollenbarger; Krista M Lisdahl
Journal:  Am J Drug Alcohol Abuse       Date:  2016-04-13       Impact factor: 3.829

Review 7.  Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.

Authors:  Maureen L Petrunich-Rutherford; Michael W Calik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders.

Authors:  Malvika Kaul; Phyllis C Zee; Ashima S Sahni
Journal:  Neurotherapeutics       Date:  2021-02-12       Impact factor: 7.620

9.  Potential effects of cannabidiol as a wake-promoting agent.

Authors:  Eric Murillo-Rodríguez; Andrea Sarro-Ramírez; Daniel Sánchez; Stephanie Mijangos-Moreno; Alma Tejeda-Padrón; Alwin Poot-Aké; Khalil Guzmán; Elda Pacheco-Pantoja; Oscar Arias-Carrión
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

10.  No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.

Authors:  Ila M P Linares; Francisco S Guimaraes; Alan Eckeli; Ana C S Crippa; Antonio W Zuardi; Jose D S Souza; Jaime E Hallak; José A S Crippa
Journal:  Front Pharmacol       Date:  2018-04-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.